Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: J Heart Lung Transplant. 2015 Jun 11;34(11):1385–1389. doi: 10.1016/j.healun.2015.05.027

Table 1.

Baseline characteristics

Variables NRI cohort (n = 160) Other patients (n = 254)
Age (years) 54±13 58±14*
Gender (female) 23% 28%
Race (Caucasian) 63% 59%
Body mass index (kg/m2) 29±7 29±7
Length of stay (days) 8±6 9±7
Ischemic etiology 48% 52%
History of:
    Hypertension 46% 48%
    Diabetes mellitus 31% 32%
    COPD 18% 17%
Heart rate (beats/min) 82±16 82±15
Systolic blood pressure (mmHg) 103±15 106±17
Serum sodium (mEq/L) 137±4 137±5
Blood urea nitrogen (mg/dL) 34±19 36±24
Serum creatinine (mg/dL) 1.5±0.6 1.5±0.6
BNP (pg/mmol) 950±110 1037±96
Transplant/LVAD within 6 months 11% 9%
Observed 6-month mortality 19% 20%

Abbreviations: BNP, B-type natriuretic peptide; COPD, chronic obstructive pulmonary disease; ESCAPE, Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness; LVAD, left ventricular assist device; NRI, nutritional risk index

p < .05 for comparison between groups